Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Submitted by
admin
on June 26, 2013 - 10:44am
Source:
Yahoo
News Tags:
Medivation
Astellas
Enzalutamide
breast cancer
Headline:
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Do Not Allow Advertisers to Use My Personal information
